Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer

NCT00003696 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: carboplatin
DRUG: cyclophosphamide
DRUG: doxorubicin hydrochloride
DRUG: etoposide
DRUG: paclitaxel

Sponsor

Commissie Voor Klinisch Toegepast Onderzoek